Physician profile
Sofya Kuznetsov
NPI 1669708020
$16,637.13
in general payments reported to CMS, 2019-2025
21 companies · $2,391 in 2025
The $2,391 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,704 · 2020: $2,544 · 2021: $259 · 2022: $2,672 · 2023: $5,110 · 2024: $1,957 · 2025: $2,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,109 · Food and Beverage: $4,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,109.40 |
| Food and Beverage | $4,348.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,118.93 | 2019-2025 | Aveir, Jeti |
| Boston Scientific Corporation | $5,489.79 | 2019-2025 | General - Therapies, Emblem Mri S-Icd, Resonate El Icd Vr |
| Biosense Webster, INC. | $968.43 | 2019-2025 | Carto 3, Soundstar, Octaray Mapping Catheter |
| Novartis Pharmaceuticals Corporation | $487.54 | 2019-2024 | |
| Medtronic Vascular, INC. | $426.80 | 2019-2020 | |
| Medtronic, INC. | $273.45 | 2021-2024 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Atricure, INC. | $259.22 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $114.15 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.96 | 2019-2023 | Lifevest |
| Sanofi-Aventis U.S. LLC | $84.12 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $61.69 | 2019-2022 | |
| Amgen INC. | $54.04 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $34.92 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $27.68 | 2019 | |
| Ethicon US, LLC | $24.64 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $23.88 | 2019-2020 | |
| Lundbeck LLC | $20.06 | 2019 | |
| Cardiovascular Systems INC. | $16.73 | 2020 | |
| Portola Pharmaceuticals, LLC | $14.89 | 2019 | |
| Pfizer INC. | $12.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofya Kuznetsov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.